当前位置: X-MOL首页全球导师 国内导师 › 刘子维

研究领域

天然产物的衍生化合成与药效学评价

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

1. Liu ZW, Liu ZM, Zhang XL, Xue PP, Zhang H. RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin. Biomedicine & Pharmacotherapy, 2014, 68, 439-445 2. Liu ZW, Yuan QY, Zhang XN, Xiong CM, Xue PP, Ruan JL. RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation the HIF-1α and inhibition phosphorylation of AKT and mTOR. Cancer Chemotherapy and Pharmacology 2012, 69(6), 1633-1640 3. Yuan QY, Liu ZW, Xiong CM, Wu LQ, Wang JP, Ruan JL. A novel, broad-spectrum antitumor compound containing the 1-hydroxycyclohexa-2,5-dien-4-one group: the disclosure of a new antitumor pharmacophore in protoapigenone 1. Bioorganic & Medicinal Chemistry Letters 2011, 21(11), 3427-3430. (SCI, IF: 2.661) 4. 刘子维,薛聘聘,石犊,赵洋,阮金兰。普通针毛蕨的化学成分和药理学活性研究进展[OL]。科技论文在线. 2013

推荐链接
down
wechat
bug